West Pharmaceutical Services (WST) Goodwill & Intangibles (2009 - 2026)

West Pharmaceutical Services (WST) has reported Goodwill & Intangibles for 18 consecutive years, with $115.1 million the latest figure, recorded in Q2 2026.

• Quarterly Goodwill & Intangibles fell 4.56% year-over-year to $115.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $115.1 million (down 4.56% YoY) and the FY2025 annual result came in at $117.6 million, up 0.68% from the prior year.
• Goodwill & Intangibles slipped to $115.1 million in Q2 2026 per WST's latest filing, from $116.2 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for WST reached as high as $130.6 million in Q1 2022 and fell as low as $115.1 million in Q2 2026.
• A 5-year average of $121.5 million and a median of $121.3 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles declined 9.56% — and 2025, when it climbed 0.68%.
• Year by year, Goodwill & Intangibles stood at $125.7 million in 2022, then retreated by 1.67% to $123.6 million in 2023, then fell by 5.5% to $116.8 million in 2024, then gained by 0.68% to $117.6 million in 2025, then slipped by 2.13% to $115.1 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $115.1 million, $116.2 million, and $117.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.